covid
Buscar en
Revista Internacional de Andrología
Toda la web
Inicio Revista Internacional de Andrología Is there a relationship between penile vasculogenic erectile dysfunction, platel...
Información de la revista
Vol. 15. Núm. 2.
Páginas 64-69 (abril - junio 2017)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
175
Vol. 15. Núm. 2.
Páginas 64-69 (abril - junio 2017)
Original
Acceso a texto completo
Is there a relationship between penile vasculogenic erectile dysfunction, platelet functions and eosinophil count?
Existe una relación entre la disfunción eréctil vasculogénica del pene, las funciones de plaquetas y el conteo de eosinófilos?
Visitas
175
Mehmet Giray Sönmeza,
Autor para correspondencia
drgiraysonmez@gmail.com

Corresponding author.
, Leyla Öztürk Sönmezb, Yunus Emre Göğera, Arif Aydına, Erhan Demirellic, Mehmet Salih Boğad, Cengiz Karae
a Department of Urology, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
b Department of Physiology, Selcuklu Medical School, Selcuk University, Konya, Turkey
c Department of Urology, Giresun Medical Faculty, Giresun University, Giresun, Turkey
d Department of Urology, Kağıthane State Hospital, İstanbul, Turkey
e Department of Urology, Medical Park Hospital, Ankara, Turkey
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (2)
Table 1. Patient findings and complete blood count (CBC) values.
Table 2. Findings for sensitivity, specificity and positive predictive values of the parameters statistically significant for vasculogenic ED.
Mostrar másMostrar menos
Abstract
Purpose

Blood count parameters of patients referring with penile vasculogenic erectile dysfunction (ED) were examined in this study. It was investigated whether eosinophil count (EC), platelet count (PC) and mean platelet volume (MPV), values among the suspected predictive parameters which may affect vascular functions, have a contribution on ED pathology or not.

Materials and methods

Patients referring erectile dysfunction complaint were evaluated. Depending on the medical story, ED degree was determined by measuring International Index of Erectile Function (IIEF). Values such as hormones, complete blood count and other laboratory markers were examined. Penile doppler ultrasonography (PDU) was performed in patients suspected to have vasculogenic ED. According to PDU result, patients with vascular deficiency were included in the penile vasculogenic ED group and patients with normal results were included in the control group. 49 patients participated in the study from the penile vasculogenic ED group and 30 patients from the control group. Intergroup comparisons were performed using the Mann–Whitney U test and the chi-square (χ2) test was used to assess the relationship between categorical variables within the patient groups.

Results

Low IIEF score in vasculogenic ED group compared to the control group and high EC, MPV and PC values were detected to be statistically significant (p<0.001, p=0.026, p=0.009, p=0.029, respectively). No statistically significant difference was observed among the two groups when age, white blood cells, red blood cells or hemoglobin values are considered (p=0.332, p=0.235, p=0.127, p=0.696, respectively).

Conclusion

High MPV value and platelet count showing the platelet functions and high eosinophil count are important factors which may play a role in penile vasculogenic ED etiopathogenesis.

Keywords:
Penile vasculogenic erectile dysfunction
Eosinophil count
Mean platelet volume
Platelet count
Penile doppler ultrasonography
Resumen
Propósito

Los parámetros de conteo de sangre de los pacientes referidos con disfunción eréctil (DE) vasculogénica del pene fueron examinados en este estudio. Se investigó si los valores de conteo de eosinófilos (CE), el conteo de plaquetas (CP) y el volumen plaquetario medio (VPM), entre los parámetros predictivos sospechados de afectar las funciones vasculares, contribuyen a la patología de DE o no.

Materiales y métodos

Se evaluó a los pacientes referidos con quejas de DE. Dependiendo de su historial médico, el grado de DE fue determinado midiendo el índice internacional de función eréctil (IIFE). Se examinaron los valores de hormonas, el conteo total de sangre y otros valores de laboratorio. Se utilizó la ultrasonografía Doppler peneana (UDP) en pacientes en los que se sospechaba DE vasculogénica. Según el resultado de la UDP, los pacientes con deficiencia vascular fueron incluidos en el grupo de DE vasculogénica del pene y los pacientes con resultados normales fueron incluidos en el grupo de control. En el estudio participaron 49 pacientes en el grupo de DE vasculogénica del pene y 30 pacientes en el grupo de control. Las comparaciones intergrupales fueron realizadas utilizando el test U de Mann-Whitney y el test de la chi cuadrado (χ2) para analizar la relación entre los variable categóricos en los grupos de pacientes.

Resultados

Resultados bajos de IIFE en el grupo de DE vasculogénica comparados con el grupo de control y resultados altos de CE, VPM y PC fueron detectados como estadísticamente significativos (p<0,001, p=0,026, p=0,009 y p=0,029, respectivamente). No se observó ninguna diferencia significativa estadísticamente entre los 2 grupos cuando se consideraron los valores de edad, glóbulos blancos, glóbulos rojos y hemoglobina (p=0,332, p=0,235, p=0,127 y p=0,696, respectivamente).

Conclusión

Unos valores altos de VPM, un conteo de plaquetas que muestra las funciones de plaquetas y un conteo alto de eosinófilos son factores importantes que pueden desempeñar un papel en la etiopatogenia de la DE vasculogénica del pene.

Palabras clave:
Disfunción eréctil vasculogénica del pene
Conteo de eosinófilos
Volumen plaquetario medio
Conteo de plaquetario
Ultrasonografía Doppler peneana
Texto completo
Introduction

Erectile dysfunction (ED) is among common diseases. It was predicted that 322 million people will have ED around the world in 2025.1 In studies made on males between forty and seventy years of age, the prevalence was found 69.2% in Turkey and 52% in United States of America.2,3 Erectile dysfunction is difficulty in obtaining and maintaining adequate erection for a satisfactory sexual performance and the stability of this condition.4 Penile erection occurs due to psychological, neural, vascular and endocrine factors and a healthy interaction among them. Erectile dysfunction occurs due to problems in all these factors. ED has a prevalence increasing with age. Since penis has a special vascular network, vascular causes play an important role in ED etiology. These causes are divided into three categories as arteriogenic ED, venogenic ED and mixed vasculogenic ED.4

A metaanalysis made presented strong proofs demonstrating that ED is related to the increase in death risk caused by increased cardiovascular disease (CVD), coronary artery disease, stroke and all reasons.6 Evidences showing that ED is an early finding for coronary artery and peripheric vascular disease gradually increase.4

Platelets play an important role in the atherosclerosis formation phase. Mean platelet volume (MPV) is a significant demonstrator of platelet activity and platelet function reflecting platelet production speed and platelet stimulation. MPV is a potential indicator for thrombocyte reactivity. Large thrombocytes have a more active and more prothrombotic potential in metabolic and enzymatic aspects. Increased MPV is related with indicators demonstrating thrombocyte activity such as increased thrombocyte gathering, tromboxan synthesis and increased expression of adhesion molecules. There are studies showing that increased MPV triggers and increases atherosclerotic processes such as acute coronary syndrome, myocardium infarction and thrombosis. It is known to be connected with atherosclerosis process in penile arterial deficiency.7–10

In many studies, it was claimed that there is a relation between eosinophilia and vascular dysfunction. It is known that eosinophils play an important role in endothelial dysfunction, vasoconstriction, inflammation and thrombosis. Eosinophils stimulate thrombocyte activation and aggregation. Eosinophils also make the thrombosis formation easier by preventing thrombomodulin.9–11

Due to these reasons, the relation between vasculogenic ED and eosinophil count (EC), platelet count (PC) and MPV has become popular in recent studies. However there is a low number of studies on the subject in literature.5,9,10,12

Blood count parameters of patients referring with penile vasculogenic erectile dysfunction (ED) were examined in this study. It was investigated whether eosinophil count (EC), platelet count (PC) and mean platelet volume (MPV) values among the suspected predictive parameters which may effect vascular functions have a contribution on ED pathology or not.

Materials and methods

79 patients who referred to the hospital with erectile dysfunction complaint between October 2014 and January 2016, had PDU and whose results can be reached were included in the study. Medical history was taken in a careful and detailed way so that psychogenic and neurological factors can be eliminated and genital and neurological examinations were made. Depending on the medical story, ED degree was determined by measuring International Erectile Function Index (IIEF score). Hormonal and other laboratory values (FSH, LH, testosterone, prolactin, glycemia, urine analysis, kidney and liver function tests) and complete blood count were examined. Blood samples were drawn from the antecubital vein at 08:00–10:00 a.m. after an overnight fasting period. The blood samples were collected in tubes containing dipotassium ethylenediaminetetraacetic acid. All of the measurements were performed immediately after venipuncture to prevent in vitro platelet activation.

Penile doppler ultrasonography (PDU) was taken in patients suspected to have vasculogenic ED. After the operation, 60mg papaverine Hcl was applied by intracavernosal injection from the 1/3 zone of the penis proximally with 26 gauge 2ml injector. Afterwards, arterial and venous flows of the penis were evaluated in 5th, 10th, 15th and 20th minutes. Measurements were made with Siemens Acuson S2000, 9MHz linear probe. Arterial deficiency (arteriogenic ED) was diagnosed in patients with a peak systolic velocity (PSV) under 30cm/seconds, venous insufficiency (venogenic ED) in patients with end diastolic flow velocity (EDV) above 5cm/seconds and mixed ED. in patients with both. According to PDU result, patients with penile vasculogenic deficiency (arteriogenic+venogenic+mixed) were included in penile vasculogenic ED group and the patients with normal results were included in the control group. 49 patients participated in the study from the penile vasculogenic ED group and 30 patients from the control group.

Exclusion criteria

Using antiplatelet and anticoagulant drugs, patients with neurogenic or endocrinological ED, a history of pelvic surgery and pelvic trauma, or other vascular risk factors for ED such as diabetes, smoking, or hypertension, recently diagnosed coronary artery disease (CAD) or hematological disorder, active infectious disease, malignancy, immunological disease, or renal or hepatic failure were excluded.

Statistical analysis

Statistical analysis was performed with SPSS 15.0 for Windows version 15.0 (SPSS Inc., Chicago, IL, USA). Intergroup comparisons were performed using the Mann–Whitney U test and the chi-square (χ2) test was used to assess the relationship between categorical variables in the patient groups. Area Under the Curve was calculated by ROC regression analyses. Epidemiological diagnosis percentages were calculated by finding cut-off values.

p<0.05 was used as a threshold for statistical significance. Data were presented as means±s.d.

Results

79 patients who had penile doppler ultrasonography (PDU) and meeting the criteria were included in the study. Penile vasculogenic deficiency was reported in 49 patients and 30 patients were reported to be normal as the result of PDU. These patients were divided into two as those with penile vasculogenic ED and the control group. In penile vasculogenic ED and control group, mean ages were: 52.6±11.4 (34–66), 51.1±10.6 (23–57) (p=0.332), IIEF scores were: 7.8±2.68, 15.8±3.63 (p<0.001). Other measurements were: MPV (fL); 9.93±1.01, 8.84±0.9 (p=0.009), Platelet Count (PC) (103/μL); 256.76±58.2, 232.46±43.26 (p=0.029), Eosinophil count (EC) (103/μL); 0.34±0.14, 0.22±0.09 (0.026). White blood cells (WBC) were measured as (103/μL); (WBC) (103/μL); 7.56±1.23, 7.36±1.06 (p=0.235), Red blood cells (RBC) (106/μL); 4.62±0.96, 4.26±0.85 (p=0.127), and Hemoglobin (Hgb) level (g/dL) as; 14.01±1.78, 13.69±1.59 (p=0.696). Low IIEF score in vasculogenic ED group compared to the control group and high EC, MPV and PC values were detected to be statistically significant (p<0.001, p=0.026, p=0.009, p=0.029, respectively). No statistically significant difference was observed among the two groups when age, WBC, RBC and Hgb values are considered (p=0.332, p=0.235, p=0.127, p=0.696, respectively). Findings for the patients and Complete Blood Count (CBC) values can be seen in Table 1.

Table 1.

Patient findings and complete blood count (CBC) values.

  Penile vasculogenic ED group  Control group  p Value 
Number  49 (%62.02)  30 (%37.97)   
Mean age  52.6±11.6 (34–66)  51.1±10.6 (23–57)  0.332 
IIEF score  7.8±2.68  15.8±3.63  <0.001 (s) 
MPV (fL)  10.21±1.23  8.84±0.9  0.009 (s) 
PC (103/μL)  256.76±58.2  232.46±43.26  0.029 (s) 
EC (103/μL)  0.34±0.14  0.22±0.09  0.026 (s) 
WBC (103/μL)  7.56±1.23  7.36 ±1.06  0.235 
RBC (106/μL)  4.62±0.96  4.26±0.85  0.127 
Hgb (g/dL)  14.01±1.78  13.69±1.59  0.696 

Abbreviations: IIEF, International Index of Erectile Function; MPV, mean platelet volume; PC, platelet count; EC, eosinophil count; WBC, white blood cells; RBC, red blood cells; Hgb, hemoglobin; s, significant. Values are presented as mean±s.d.

Statistically significant values are written with bold values.

In the evaluation made with Roc regression analysis, statistically significant values for Vasculogenic ED were measured as:

  • MPV value – sensitivity: 56.5%, specificity: 91%, positive predictive value 86%.

  • EC – sensitivity: 65%, specificity: 78%, positive predictive value: 74%.

  • PC – sensitivity: 60%, specificity: 63%, positive predictive value: 62.5%. Findings for sensitivity, specificity and positive predictive values of the parameters statistically significant for vasculogenic ED are available in Table 2.

    Table 2.

    Findings for sensitivity, specificity and positive predictive values of the parameters statistically significant for vasculogenic ED.

      Sensitivity (%)  Specificity (%)  Positive predictive value (%)  p Value 
    MPV  56.5  91  86  0.009 
    EC  65  78  74  0.026 
    PC  60  63  62.5  0.029 

    Abbreviations: MPV, mean platelet volume; PC, platelet count; EC, eosinophil count.

Discussion

Erectile dysfunction (ED) is a disease increasing with age. Its incidence shows a significant increase after 40 years of age especially. It was also detected to be between 1 and 10% even in males under 40 years of age in the studies made.13,14

Organic and psychological factors play a role in erectile dysfunction development. Organic causes play a more dominant role in ED etiology and vascular factors outstand among the organic causes of ED.15 So diseases causing vascular pathologies such as hypertension, hyperlipidemia, diabetes mellitus and coronary artery disease are the main risk factors for vasculogenic ED and this risk increases nearly 1.5–4 times in the presence of these risk factors.16,17 Vasculogenic ED is related to impairment of endothelium-dependent and endothelium-independent relaxations of smooth muscle cells and atherosclerotic occlusion in cavernous arteries. Since atherosclerosis affects all vascular bed, the earliest symptom development is expected in the artery with the narrowest vein lumen. Since the lumen of penile artery is between 1 and 2mm, symptoms based on atherosclerosis in penile artery are observed in early period.4,18,19

Vasculogenic ED plays an important and major role among ED causes. Since MPV and PC are significant demonstrators of platelet function and activation and thromboembolic event incidence increases with platelet activation, the relation between vasculogenic ED and MPV and platelet number is gradually becoming more important.

Eosinophils activate coagulation system and thrombocytes. This situation may cause vasospasm in arteries. It was reported that eosinophil granule proteins may affect cardiovascular system negatively by causing vascular injury and inflammatory cell infiltration. Previous studies demonstrated that eosinophils are related with stent thrombosis, stent restenosis and acute coronary syndromes.9,20 There are studies reporting that eosinophil count is related to vasospastic angina pectoris and large thrombus formation.21 Strong vasoconstrictor and procoagulant effects of eosinophils make us consider the presence of a relation between eosinophil count and vasculogenic ED. Thus eosinophil count was also included as a suspicious predictive factor in the current study.

Çiftci et al. (2013) compared 50 patients with vasculogenic ED with 40 healthy people and stated that MPV values and platelet number are statistically higher in vasculogenic ED group statistically. In this study, vascular endothelial cell damage occurring with thrombocyte activation was held responsible for vasculogenic ED etiopathogenesis.10

In a recent study made in 2015, three groups including vasculogenic ED, ED after radical prostatectomy (nonvasculogenic ED) and control group were compared and it was reported that MPV values and platelet count was statistically higher in vasculogenic ED group.5

Otunctemur et al. (2015) vasculogenic ED patients were compared with healthy control group and in addition to MPV and platelet count, eosinophil count was also included in examination. Although MPV values and platelet count was found statistically higher in vasculogenic ED group, no difference was found in eosinophil count among the two groups which is different from our study.9 The reason may be the fact that most of the patient group with vasculogenic ED in our study are arteriogenic ED patients. Ratio of patients with pure arteriogenic ED in the vasculogenic ED group in our study was 69.3% (34/49). Since thrombosis plays a significant role in arteriogenic ED etiology, high eosinophils may have increased arterial thrombosis potential. This condition may be the reason explaining a different result from the study by Otunctemur et al.

Aldemir et al. (2016) reported that among ED and healthy control group, mean platelet volume (MPV) and platelet distribution width (PDW) values are significantly higher in erectile dysfunction group but the platelet count is not different among the two groups. We think that the patients being general ED and not being specified as vasculogenic ED decrease the reliability of this study.12

In our study, we detected a significant difference between MPV, PC, EC values among the two groups and in penile vasculogenic ED group, MPV, PC and EC values were detected significantly high statistically (p=0.009, p=0.029, p=0.026, respectively).

MPV and PC values were detected high in penile arteriogenic ED group similar to the studies made before.5,9,10 This situation shows that MPV and PC values are a strong predictive factor for both specific penile arteriogenic ED and vasculogenic ED (arteriogenic+venogenic+mixed). However eosinophil count was detected significantly higher in penile arteriogenic ED group which is different from the study by Otunctemur et al.9

This situation suggests that eosinophil count plays a vasculogenic active role. Studies demonstrating that increasing eosinophil count has negative effects on coronary arteries were published.20,21 Based on the negative effect of increasing eosinophil count on arteries and the results of our study, we believe that eosinophil count could be an important factor in etiopathogenesis of penile vasculogenic ED. Since our results are different from the only study.9 We think that this study will make a significant contribution to literature based on its results and compared to the studies made with patients including general ED groups.

Since high MPV, PC and EC values carry vascular dysfunction risk, these patients should be examined carefully for possible asymptomatic cardiovascular system disease. System evaluation should be recommended even though a there is no known cardiovascular disease in this patient group when these values are high and erectile dysfunction is accompanying. Treatment options should be evaluated considering that vascular dysfunction may play a more active role in the etiology in erectile dysfunction accompanied by high MPV, PC and EC values.

Conclusion

High MPV value and platelet count showing the platelet functions and high eosinophil count are important factor which may play a role in penile vasculogenic ED etiopathogenesis. We do not think that other blood count parameters such as WBC, RBC and Hbg play an active role in penile vasculogenic ED pathogenesis. High MPV, PC, EC values may give a clue about the vasculogenic ED etiology diagnosis without doing diagnostic invasive operations. We think that studies including a patient group including more patients and separate arteriogenic, venogenic, mixed ED patient groups would be more useful on this subject.

Ethical disclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent

The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.

Conflict of interest

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors received no financial support for the research, authorship, and/or publication of this article.

Acknowledgement

This article is in accordance with ethical standards and has been approved by local authorities.

References
[1]
I.A. Ayta, J.B. McKinlay, R.J. Krane.
The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences.
BJU Int, 84 (1999), pp. 50-56
[2]
E. Akkus, A. Kadioglu, A. Esen, S. Doran, A. Ergen, K. Anafarta, et al.
Prevalence and correlates of erectile dysfunction in Turkey: a population-based study.
Eur Urol, 41 (2002), pp. 298-304
[3]
H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, J.B. McKinlay.
Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study.
J Urol, 151 (1994), pp. 54-61
[4]
Hatzimouratidis K, Eardley I, Giuliano F, Moncada I, Salonia A. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. European Association of Urology Web site. http://uroweb.org/guideline/male-sexual-dysfunction/. Updated 2015. Eur Urol. 2015 Oct;68(4):e77. doi: 10.1016/j.eururo.2015.06.013. Epub 2015 Jun 29.
[5]
H. Ciftci, K. Gumus, I. Yagmur, S. Sahabettin, H. Çelik, E. Yeni, et al.
Assessment of mean platelet volume in men with vasculogenic and nonvasculogenic erectile dysfunction.
Int J Impot Res, 27 (2015), pp. 38-40
Epub 2014 May 29
[6]
J.Y. Dong, Y.H. Zhang, L.Q. Qin.
Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies.
J Am Coll Cardiol, 58 (2011), pp. 1378-1385
[7]
L. Pizzulli, A. Yang, J.F. Martin, B. Lüderitz.
Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain.
Eur Heart J, 19 (1998), pp. 80-84
[8]
S. Kamath, A.D. Blann, G.Y. Lip.
Platelet activation: assessment and quantification.
Eur Heart J, 22 (2001), pp. 1561-1571
[9]
A. Otunctemur, M. Bozkurt, H. Besiroglu, E.C. Polat, L. Ozcan, E. Ozbek.
Erectile dysfunction is positively correlated with mean platelet volume and platelet count, but not with eosinophil count in peripheral blood.
Urol J, 12 (2015), pp. 2347-2352
[10]
H. Ciftci, E. Yeni, M. Demir, I. Yagmur, K. Gümüş, H. Celik, et al.
Can the mean platelet volume be a risk factor for vasculogenic erectile dysfunction?.
World J Mens Health, 31 (2013), pp. 215-219
Epub 2013 Dec 24
[11]
J. Wang, S.A. Mahmud, J.A. Thompson, J.G. Geng, N.S. Key, A. Slungaard.
The principal eosinophil peroxidase product. HOSCN. Is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states?.
Blood, 107 (2006), pp. 558-565
[12]
M. Aldemir, F. Akdemir, E. Okulu, K. Ener, A. Ozayar, A. Gudeloglu.
Evaluation of blood platelet count and function in patients with erectile dysfunction.
Andrologia, 48 (2016), pp. 189-192
Epub 2015 Apr 29
[13]
R.W. Lewis, K.S. Fugl-Meyer, G. Corona, R.D. Hayes, E.O. Laumann, E.D. Moreira Jr., et al.
Definitions/epidemiology/risk factors for sexual dysfunction.
J Sex Med, 7 (2010), pp. 1598-1607
[14]
C.G. Bacon, M.A. Mittleman, I. Kawachi, E. Giovannucci, D.B. Glasser, E.B. Rimm.
Sexual function in men older than 50 years of age: results from the health professionals follow- up study.
Ann Intern Med, 139 (2003), pp. 161-168
[15]
A. Mehta, M. Miner, M. Sigman.
Assessment of EndoPAT scores in men with vasculogenic and non-vasculogenic erectile dysfunction.
Int J Clin Pract, 67 (2013), pp. 46-51
[16]
A. Kefi, Ö. Demir, M. Seçil, A. Esen.
Doppler ultrasonography in erectile dysfunction patients with risk factors.
Turk J Urol, 31 (2005), pp. 202-206
[17]
A. Martin-Morales, J.J. Sanchez-Cruz, I. Saenz de Tejada, L. Rodriguez-Vela, J.F. Jimenez-Cruz, R. Burgos-Rodriguez.
Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfunction Erectil Masculina Study.
J Urol, 166 (2001),
569
[18]
C. Persu, V. Cauni, S. Gutue, E.S. Albu, V. Jinga, P. Geavlete.
Diagnosis and treatment of erectile dysfunction – a practical update.
J Med Life, 2 (2009), pp. 394-400
[19]
P. Montorsi, F. Montorsi, C.C. Schulman.
Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder?.
Eur Urol, 44 (2003), pp. 352-354
[20]
S. Umemoto, N. Suzuki, K. Fujii, A. Fujii, T. Fujii, T. Iwami, et al.
Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris.
Am J Cardiol, 85 (2000), pp. 715-719
[21]
T. Sakai, S. Inoue, T.A. Matsuyama, M. Takei, H. Ota, T. Katagiri, et al.
Eosinophils may be involved in thrombus growth in acute coronary syndrome.
Int Heart J, 50 (2009), pp. 267-277
Copyright © 2016. Asociación Española de Andrología, Medicina Sexual y Reproductiva
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos